VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares were down 14.7% on Tuesday . The stock traded as low as C$0.15 and last traded at C$0.15. Approximately 266,015 shares changed hands during trading, a decline of 10% from the average daily volume of 294,436 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Stock Down 14.7 %
The stock’s fifty day moving average price is C$0.10 and its 200-day moving average price is C$0.13. The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56. The company has a market capitalization of C$23.52 million, a price-to-earnings ratio of -4.48 and a beta of 0.39.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- Stock Market Sectors: What Are They and How Many Are There?
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- How to Capture the Benefits of Dividend Increases
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- What Are Earnings Reports?
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
